Literature DB >> 17721078

The Par-1/MARK family of protein kinases: from polarity to metabolism.

Jonathan Hurov1, Helen Piwnica-Worms.   

Abstract

The Par-1 protein kinases are conserved from yeast to man and belong to a subfamily of kinases that includes the energy sensor and metabolic regulator, AMPK. Par-1 is regulated by LKB1 and atypical PKC and has been shown in multiple organisms and cell types to be critical for regulation of cellular polarity. Recent studies using knockout mice have revealed several surprising physiological functions for Par-1b/MARK2/EMK1. Our recent study shows that Par-1b regulates metabolic rate, adiposity and insulin sensitivity. This is the first study to implicate these kinases in metabolic functions akin to those previously defined for AMPK. Conversely, another series of recent publications now implicate AMPK in regulation of polarity. Here we discuss the metabolic phenotype seen in Par-1b deficient mice and the synthesis of several findings that link Par-1 and AMPK to a degree that has not been previously appreciated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17721078     DOI: 10.4161/cc.6.16.4576

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  28 in total

1.  SAD-A and AMPK kinases: the "yin and yang" regulators of mTORC1 signaling in pancreatic β cells.

Authors:  Jia Nie; Xiao Han; Yuguang Shi
Journal:  Cell Cycle       Date:  2013-09-18       Impact factor: 4.534

2.  Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin-binding protein-dependent reduction of β-catenin.

Authors:  Amy K Rines; Michael A Burke; Richard P Fernandez; Olga V Volpert; Hossein Ardehali
Journal:  FASEB J       Date:  2012-08-08       Impact factor: 5.191

Review 3.  Epidermal polarity genes in health and disease.

Authors:  Frederik Tellkamp; Susanne Vorhagen; Carien M Niessen
Journal:  Cold Spring Harb Perspect Med       Date:  2014-12-01       Impact factor: 6.915

4.  MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells.

Authors:  Emad Heidary Arash; Ahmed Shiban; Siyuan Song; Liliana Attisano
Journal:  EMBO Rep       Date:  2017-02-09       Impact factor: 8.807

5.  Phospho-dependent ubiquitination and degradation of PAR-1 regulates synaptic morphology and tau-mediated Aβ toxicity in Drosophila.

Authors:  Seongsoo Lee; Ji-Wu Wang; Wendou Yu; Bingwei Lu
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

6.  Influence of cell polarity on early development of the sea urchin embryo.

Authors:  Kathleen S Moorhouse; Heather F M Gudejko; Alex McDougall; David R Burgess
Journal:  Dev Dyn       Date:  2015-09-25       Impact factor: 3.780

7.  Discovery of cellular substrates for protein kinase A using a peptide array screening protocol.

Authors:  F Donelson Smith; Bret K Samelson; John D Scott
Journal:  Biochem J       Date:  2011-08-15       Impact factor: 3.857

8.  Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis.

Authors:  Jochen K Lennerz; Jonathan B Hurov; Lynn S White; Katherine T Lewandowski; Julie L Prior; G James Planer; Robert W Gereau; David Piwnica-Worms; Robert E Schmidt; Helen Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2010-08-23       Impact factor: 4.272

9.  LKB1 inhibition of NF-κB in B cells prevents T follicular helper cell differentiation and germinal center formation.

Authors:  Nicole C Walsh; Lynnea R Waters; Jessica A Fowler; Mark Lin; Cameron R Cunningham; David G Brooks; Jerold E Rehg; Herbert C Morse; Michael A Teitell
Journal:  EMBO Rep       Date:  2015-04-26       Impact factor: 8.807

10.  A genetic screen identifies an LKB1-MARK signalling axis controlling the Hippo-YAP pathway.

Authors:  Morvarid Mohseni; Jianlong Sun; Allison Lau; Stephen Curtis; Jeffrey Goldsmith; Victor L Fox; Chongjuan Wei; Marsha Frazier; Owen Samson; Kwok-Kin Wong; Kwok-Kim Wong; Carla Kim; Fernando D Camargo
Journal:  Nat Cell Biol       Date:  2013-12-22       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.